SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013341
Filing Date
2022-05-13
Accepted
2022-05-13 16:32:09
Documents
70
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1283089
2 ex31-1.htm EX-31.1 11876
3 ex31-2.htm EX-31.2 11649
4 ex32-1.htm EX-32.1 4863
5 ex32-2.htm EX-32.2 4865
  Complete submission text file 0001493152-22-013341.txt   5940472

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE aim-20220331.xsd EX-101.SCH 41832
7 XBRL CALCULATION FILE aim-20220331_cal.xml EX-101.CAL 50419
8 XBRL DEFINITION FILE aim-20220331_def.xml EX-101.DEF 206229
9 XBRL LABEL FILE aim-20220331_lab.xml EX-101.LAB 358484
10 XBRL PRESENTATION FILE aim-20220331_pre.xml EX-101.PRE 289238
64 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1032745
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-27072 | Film No.: 22923318
SIC: 2836 Biological Products, (No Diagnostic Substances)